FastMDx®

NGX 124

An Open MDx Platform

Fully Automated Liquid Handling
and Ultra-Fast qPCR

NGX 124 MDx diagnostics test platform
NGX 124 MDx diagnostics test platform
NGX 124 MDx diagnostics test platform

Open – Low Cost – High-Throughput – Mobile – LIMS integrated – Compact

The NGX 124 is a fully open, automated molecular diagnostics (MDx) test platform, offering a significant advantage over other systems.

It supports all Laboratory Developed Tests (LDTs), Research Use Only (RUO), and approved assays sourced directly from a wide range of small and medium sized assay manufacturers.

UKCA marked
CE-IVDR marked

Technology

Jointly designed and developed by Fast MDx and Festo, the Fast MDx platform is the first fully automated, high-throughput, mobile Molecular Diagnostic (MDx) test platform and incorporates Fast MDx’s latest, ultra-fast, “NGx2” 4-Channel qPCR thermal cycler and Reverse Transcription “RT” block technology…

Specification

Compact, mobile and rugged on 4 lockable casters, Fast MDx can be used anywhere in the World. Small enough to fit through any doorway and into any elevator, Fast MDx is as much at home in a biosecure laboratory as it is in a hospital facility…

Benefits

Fast MDx aims to provide affordable MDx to all peoples of the world, regardless of income or location…